Jon D. Morrow, MD, MBA

About Me

Conditions and Treatments

annual GYN screening

Credentials

Positions

Clinical Associate Professor, Department of Obstetrics and Gynecology

Board Certifications

American Board of Obstetrics & Gynecology - Obstetrics & Gynecology, 1995

Education and Training

MBA from Columbia University, 2002
Residency, Northwestern University - Prentice Women's Hospital, Obstetrics & Gynecology, 1993
MD from McGill University, 1989

Departments

Obstetrics and Gynecology

Is this your profile?

Edit profile

Is this your profile?

Edit profile

Locations and Appointments

Tisch Hospital, Labor & Delivery

550 First Avenue, 8th Floor
New York, NY 10016

Phone

212-263-5640

View Map

Research My Research

Interests

informatics, EMR usability, overactive bladder, OAB, healthcare IT , clinical workflows, EHR usability, user-interface design, quality improvement, medical quality

Academic office

550 First Avenue

TH8

New York, NY 10016

Phone

212-263-5640

These focus areas and their associated publications are derived from PubMed and the MeSH term library.

represents one publication

Loading...

Publications

Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials

DuBeau, Catherine E; Morrow, Jon D; Kraus, Stephen R; Creanga, Dana; Bavendam, Tamara

Neurourology & urodynamics. 2012 Nov ; 31(8):1258-65
The effect of elective sham dose escalation on the placebo response during an antimuscarinic trial for overactive bladder symptoms

Staskin, David R; Michel, Martin C; Sun, Franklin; Guan, Zhonghong; Morrow, Jon D

Journal of urology. 2012 May ; 187(5):1721-6
Effects of voluntary dose escalation in a placebo-controlled, flexible-dose trial of fesoterodine in subjects with overactive bladder

Staskin, David; Khullar, Vik; Michel, Martin C; Morrow, Jon D; Sun, Franklin; Guan, Zhonghong; Dmochowski, Roger

Neurourology & urodynamics. 2011 Nov ; 30(8):1480-5

Read All Publications (12)

Conditions We Treat

Our Story

Jon D. Morrow, MD, MBA

About Me

Conditions and Treatments

Credentials

Positions

Board Certifications

Education and Training

Departments

Locations and Appointments

Tisch Hospital, Labor & Delivery

Phone

Research My Research

Interests

Academic Contact

Academic office

Phone

Research Interests Timeline

Publications

Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials

The effect of elective sham dose escalation on the placebo response during an antimuscarinic trial for overactive bladder symptoms

Effects of voluntary dose escalation in a placebo-controlled, flexible-dose trial of fesoterodine in subjects with overactive bladder